| Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals S Wang, R Su, S Nie, M Sun, J Zhang, D Wu, N Moustaid-Moussa The Journal of nutritional biochemistry 25 (4), 363-376, 2014 | 485 | 2014 |
| Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals C Li, J Zhang, Y Zu, S Nie, J Cao, Q Wang, S Nie, Z Deng, M Xie, S Wang Chinese journal of natural medicines 13 (9), 641-652, 2015 | 136 | 2015 |
| Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells RCC de Pace, X Liu, M Sun, S Nie, J Zhang, Q Cai, W Gao, X Pan, Z Fan, ... Journal of liposome research 23 (3), 187-196, 2013 | 126 | 2013 |
| Detection and treatment of atherosclerosis using nanoparticles J Zhang, Y Zu, CS Dhanasekara, J Li, D Wu, Z Fan, S Wang Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 9 (1), e1412, 2017 | 111 | 2017 |
| Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages J Zhang, S Nie, S Wang Journal of agricultural and food chemistry 61 (38), 9200-9209, 2013 | 92 | 2013 |
| Handbook of clinical nanomedicine: nanoparticles, imaging, therapy, and clinical applications R Bawa, GF Audette, I Rubinstein CRC Press, 2016 | 66 | 2016 |
| Differential effects on adiposity and serum marker of bone formation by post-weaning exposure to methylparaben and butylparaben P Hu, RC Kennedy, X Chen, J Zhang, CL Shen, J Chen, L Zhao Environmental Science and Pollution Research 23, 21957-21968, 2016 | 61 | 2016 |
| Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles J Zhang, S Nie, R Martinez-Zaguilan, SR Sennoune, S Wang The Journal of nutritional biochemistry 30, 14-23, 2016 | 47 | 2016 |
| Detection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesicles S Nie, J Zhang, R Martinez-Zaguilan, S Sennoune, MN Hossen, ... Journal of Controlled Release 220, 61-70, 2015 | 40 | 2015 |
| Enhanced oral bioavailability of quercetin by nanostructured lipid carriers M Sun, S Wang, S Nie, J Zhang The FASEB Journal 28 (1 Supplement), 1044.24, 2014 | 7 | 2014 |
| Anti-Atherogenic Effects of Lesion-Targeted Epigallocatechin Gallate (EGCG)-Loaded Nanoparticles J Zhang, S Nie, MN Hossen, M Sun, R Martinez-Zaguilan, S Sennoune, ... The FASEB Journal 29 (1 Supplement), 271.3, 2015 | 2 | 2015 |
| Comparing Effects of Native and Nanoencapsualted Epigallocatechin Gallate on Liver Fat Content in LDL Receptor Null Mice C Li, J Zhang, S Nie, J Cao, S Wang The FASEB Journal 29 (1 Supplement), LB373, 2015 | 1 | 2015 |
| Epigallocatechin gallate (EGCG)-loaded nanoparticles decrease cholesterol content in THP-1 derived macrophages J Zhang, S Nie, S Wang The FASEB Journal 27 (1_MeetingAbstracts), 224.5, 2013 | 1 | 2013 |
| 不同配比的功能性脂肪酸对摄入反式脂肪酸大鼠的血脂及组织脂肪酸代谢的影响 张佳 南昌: 南昌大学, 2011 | 1 | 2011 |
| Detection of Intimal Macrophages in Atherosclerotic Lesions Using Biocompatible CD36‐Targeted Ligand Containing Nanoparticle CS Dhanasekara, J Zhang, S Nie, S Wang The FASEB Journal 30, 431.4-431.4, 2016 | | 2016 |
| Effects of Epigallocatechin Gallate Nanocarriers on Liver Cholesterol Content in LDL Receptor Null Mice J Cao, J Zhang, C Li, S Wang The FASEB Journal 29, LB369, 2015 | | 2015 |
| Molecular Imaging and prevention of Atherosclerosis using CD36-targeted nanoparticles and Epigallocatechin gallate J Zhang | | 2015 |
| The effect of EGCG and EGCG nanoparticles on body weight and body composition in LDL receptor null mice Y Zu, J Zhang, S Nie, S Wang FASEB JOURNAL 29, 2015 | | 2015 |
| Detection of Intimal Macrophages in Atherosclerotic Lesions Using a CD36-Targeted Ligand Containing Nanoparticle C Dhanasekara, J Zhang, S Nie, S Wang The FASEB Journal 29 (1 Supplement), 606.12, 2015 | | 2015 |
| The antiatherogenic effects of targeted epigallocatechin gallate-loaded nanoparticles J Zhang The FASEB Journal 28 (1 Supplement), 1045.41, 2014 | | 2014 |
